McKesson’s Q2 FY2027 earnings estimates ahead of November 4 report
Published November 3; ahead of the November 4 report, Zacks estimated fiscal Q2 EPS at $10.69 versus $9.86 a year earlier and revenue at $110.11B versus $106.16B. Zacks said EPS estimates were unchanged over the prior seven days and cited prescription volumes and Oncology & Multispecialty as supports, with pricing pressure a challenge.
McKesson Q2 Earnings Call Highlights - Yahoo Finance
McKesson's second-quarter revenue rose 8% year over year to $111 billion. [[fact-gttcj13ic]] Adjusted diluted earnings per share increased 18% to $11.68. [[fact-bg7i64q5o]] The company raised its fiscal 2027 adjusted diluted earnings outlook to $45.60–$46.40 per share. [[fact-0ojqp9wp4]] Its previous adjusted earnings forecast was $44.20–$45.00 per share. [[fact-k62pahppt]]
McKesson (MCK) Q2 2027 Earnings Call Transcript
McKesson (MCK) Q2 2027 Earnings Call Transcript(摘要待生成)
McKesson Raises FY2027 Adj EPS Guidance from $44.20-$45.00 to $45.60-$46.40 vs $44.71 Est
McKesson Raises FY2027 Adj EPS Guidance from $44.20-$45.00 to $45.60-$46.40 vs $44.71 Est(摘要待生成)
McKesson 8-K (2.02, 9.01): reported results of operations
McKesson reported fiscal second-quarter revenue of $111.0 billion, up 8%, and adjusted diluted EPS of $11.68, up 18%, and raised fiscal 2027 adjusted EPS guidance to $45.60–$46.40 from $44.20–$45.00.
Mckesson outlines fiscal 2027 adjusted EPS of $45.60-$46.40 while closing $2.25B Precision Medicine Group deal
Mckesson outlines fiscal 2027 adjusted EPS of $45.60-$46.40 while closing $2.25B Precision Medicine Group deal(摘要待生成)
Option Care Health Reports Q3 2026 Results Amid Pending Acquisition by McKesson
Option Care Health released its third-quarter 2026 financial results while noting its pending acquisition by McKesson Corporation and Clayton, Dubilier & Rice, LLC.
Morgan Stanley lifts McKesson price target to $1,207
Published October 31; event October 30, 2026: Morgan Stanley analyst Erin Wright raised the target to $1,207 from $977 and maintained Overweight. McKesson closed at $994.58 on October 30, up from $980.88 on October 29; no peer move was reported.
McKesson Q2 Adj. EPS $11.68 Beats $10.70 Estimate, Sales $110.957B Beat $109.875B Estimate
McKesson Q2 Adj. EPS $11.68 Beats $10.70 Estimate, Sales $110.957B Beat $109.875B Estimate(摘要待生成)
McKesson trading around analyst target increases
McKesson closed at $999.62 on November 3, 2026, up 0.12% that day. Its listed closes were $994.58 on October 30 and $1,015.50 on October 21. The page provides MCK prices, not peer comparisons or attribution to analyst actions.